TP53 and cutaneous melanoma: To exclude a putative cell line dependency of the regulation of these genes by p53, we investigated the effect of Nutlin-3 treatment in 92.1 uveal melanoma and in three cutaneous melanoma cell lines, of which MEL 94.07 contains a p53-inactivating mutation.